| __timestamp | Lantheus Holdings, Inc. | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 176081000 | 205018000 |
| Thursday, January 1, 2015 | 157939000 | 392709000 |
| Friday, January 1, 2016 | 164073000 | 299694000 |
| Sunday, January 1, 2017 | 169243000 | 397061000 |
| Monday, January 1, 2018 | 168489000 | 434100000 |
| Tuesday, January 1, 2019 | 172526000 | 782200000 |
| Wednesday, January 1, 2020 | 200649000 | 1119900000 |
| Friday, January 1, 2021 | 237513000 | 2437500000 |
| Saturday, January 1, 2022 | 353358000 | 1560400000 |
| Sunday, January 1, 2023 | 586886000 | 1815800000 |
| Monday, January 1, 2024 | 1970500000 |
In the ever-evolving landscape of biotechnology, understanding cost dynamics is crucial. Over the past decade, Regeneron Pharmaceuticals, Inc. and Lantheus Holdings, Inc. have showcased distinct trajectories in their cost of revenue. From 2014 to 2023, Regeneron saw a staggering 785% increase, peaking in 2021, while Lantheus experienced a 234% rise, with a notable surge in 2023. This divergence highlights Regeneron's aggressive expansion and investment in innovation, contrasted with Lantheus's steady growth strategy. By 2023, Regeneron's cost of revenue was approximately three times that of Lantheus, reflecting its larger scale and broader market reach. These trends underscore the strategic choices each company has made in navigating the competitive biotech sector. As investors and industry watchers, these insights offer a window into the operational efficiencies and market positioning of these two industry leaders.
Comparing Cost of Revenue Efficiency: Regeneron Pharmaceuticals, Inc. vs Intra-Cellular Therapies, Inc.
Cost of Revenue Comparison: Regeneron Pharmaceuticals, Inc. vs Incyte Corporation
Regeneron Pharmaceuticals, Inc. vs Veracyte, Inc.: Efficiency in Cost of Revenue Explored
Cost Insights: Breaking Down Regeneron Pharmaceuticals, Inc. and Perrigo Company plc's Expenses
Cost of Revenue Trends: Regeneron Pharmaceuticals, Inc. vs ACADIA Pharmaceuticals Inc.
Cost Insights: Breaking Down Regeneron Pharmaceuticals, Inc. and Iovance Biotherapeutics, Inc.'s Expenses
Regeneron Pharmaceuticals, Inc. vs Xencor, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Exelixis, Inc. and Lantheus Holdings, Inc.
Cost of Revenue Comparison: Lantheus Holdings, Inc. vs Ionis Pharmaceuticals, Inc.
Cost of Revenue Comparison: Lantheus Holdings, Inc. vs Alkermes plc
Cost of Revenue Comparison: Lantheus Holdings, Inc. vs Vericel Corporation
Cost of Revenue Trends: Lantheus Holdings, Inc. vs Iovance Biotherapeutics, Inc.